InVivoMAb anti-rat CTLA-4 (CD152)

Induction of IL-10- and IFN-gamma-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax.

Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis.

Rapid recovery from T lymphopenia by CD28 superagonist therapy.

Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist.